M & - : & Delighted to have contributed expert commentary to the latest feature in The I-Paper (iNews) , alongside Dr Martin Whyte (University of Surrey), examining the evidence and clinical perspective behind Dr Jack Mosleys stark warning on GLP-1 weight-loss medications, especially for menopausal women
Do this calculation fresh every time
Beyond improving the metabolic profile, GLP-1 RAs have been shown to significantly reduce serum levels of CRP In summary GLP-1 receptor agonists have been shown to be effective in reducing body weight, measurements of liver injury, and liver fat content
Add intensity back slowly
Some state programs cover tirzepatide for certain conditions, while others do not
Over time, clinical research revealed a powerful secondary benefit: significant, sustained weight loss